- Home
- TIVC vs ISPC Comparison
TIVC vs ISPC Comparison
Compare TIVC & ISPC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | TIVC | ISPC |
|---|---|---|
| Founded | 2016 | 2009 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Electromedical & Electrotherapeutic Apparatus | Precision Instruments |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.6M | 3.8M |
| IPO Year | 2021 | 2020 |
Fundamental Metrics
Financial Performance| Metric | TIVC | ISPC |
|---|---|---|
| Price | $1.40 | $5.30 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 86.9K | ★ 29.7M |
| Earning Date | 05-14-2026 | 05-18-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 87.03 |
| EPS | N/A | ★ N/A |
| Revenue | $780,000.00 | ★ $1,928,998.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.75 | $0.10 |
| 52 Week High | $5.60 | $5.75 |
Technical Indicators
Market Signals| Indicator | TIVC | ISPC |
|---|---|---|
| Relative Strength Index (RSI) | 69.31 | 93.45 |
| Support Level | $0.79 | $0.45 |
| Resistance Level | $2.70 | N/A |
| Average True Range (ATR) | 0.11 | 0.34 |
| MACD | 0.03 | 0.61 |
| Stochastic Oscillator | 100.00 | 79.16 |
Price Performance
Historical ComparisonAbout TIVC Tivic Health Systems Inc.
Tivic Health Systems Inc is a late-stage biopharmaceutical company focused on the development of biologics, with its lead product candidate, Entolimod, a TLR5 agonist, being developed for acute radiation syndrome and oncology-related indications. The company operates through two segments: a biopharma segment focused on product development and commercialization, and a contract development and manufacturing organization (CDMO) segment providing manufacturing and development services through its subsidiary.
About ISPC iSpecimen Inc.
iSpecimen Inc is a technology-driven company focused on connecting life science researchers who need human biofluids, solid tissues, and hematopoietic stem and immune cells for their research with the available biospecimens. The company generates revenue by procuring various specimens from hospitals, laboratories, and other supply sites. Geographically, it has a presence in the Americas, Europe, the Middle East, Africa, and the Asia Pacific, with the majority coming from the Americas. The Company has one reportable segment: biospecimens.